Descriptive characteristics of the cancer patient population included in the trial (average and SD)
| Total | |
|---|---|
| Age (years) | 63.96 (11.04) |
| Gender | |
| Female | 55/167 (32.9%) |
| Male | 112/167 (67.1%) |
| Primary location | |
| Breast | 7/167 (4.2%) |
| GI tract | 109/167 (65.3%) |
| Lung | 32/167 (19.2%) |
| Head/neck | 19/167 (11.4%) |
| Metastases | |
| No | 54/167 (32.3%) |
| Yes | 113/167 (67.7%) |
| Cancer stage | |
| I | 21/167 (12.6%) |
| II | 23/167 (7.2%) |
| III | 21/167 (12.6%) |
| IV | 111/167 (66.5%) |
| V | 2/167 (1.2%) |
GI, gastrointestinal.